ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 700023 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 700023; 2) Community: the network communities that were significantly associated with the response to NSC 700023; 3) Molecule: the relationships between components within communities and NSC 700023; 4) MDR: the compounds that were significantly associated with the NSC 700023.

NSC Compound Enrichment Correlation
NSC 721154 11-Cyanomethylen-2-methoxy-6-methyl-11H-indolo[1,2-b]indazol ium trifluoromethanesulfonate 0.0126882509540132 -0.026623287
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0126882509540132 -0.09727939
NSC 759878 Irinotecan hydrochloride (USAN) 0.0126882509540132 -0.13817518
NSC 100880 Camptothecin 0.0126882509540134 -0.080823428
NSC 132313 Dianhydrogalactitol 0.0126882509540134 -0.23910785
NSC 154948 M-AMSA 0.0126882509540134 -0.19795159
NSC 328410 Camptothecin Derivative 0.0126882509540134 0.047116134
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0126882509540134 -0.10333347
NSC 45236 Null 0.0126882509540134 -0.062336703
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0126882509540134 -0.073236019
Total:52  Current:18    [First] [Prev] [Next] [Last]